Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Transgene to Present New Positive Preliminary Phase I Clinical Data at AACR 2022, Reinforcing the Potential of TG4050
Transgene to Present New Positive Preliminary Phase I Clinical Data at AACR 2022, Reinforcing the Potential of TG4050


Regulatory News:



Transgene (Euronext Paris: TNG) (Paris:TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, will present additional positive

Xencor Presents Data from Multiple Preclinical XmAb® Cytokine Programs at the American Association for Cancer Research (AACR) Annual Meeting 2022
Xencor Presents Data from Multiple Preclinical XmAb® Cytokine Programs at the American Association for Cancer Research (AACR) Annual Meeting 2022


Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies and cytokines for the treatment of cancer and autoimmune diseases, today announced the

AbCellera Presents Data on T Cell Engager Platform at AACR 2022
AbCellera Presents Data on T Cell Engager Platform at AACR 2022


AbCellera (Nasdaq: ABCL), a technology company focused on next-generation antibody discovery, today announced the release of data on its new T cell engager platform at the American Association for

For Canadian Mainframe Users, Cloud is the Goal
For Canadian Mainframe Users, Cloud is the Goal


Mainframes are prime targets for digital transformation at many Canadian enterprises that want to increase data access, agility and automation, according to a new research report published today by

Mainframe-to-Cloud Migration Poised to Unlock Data
Mainframe-to-Cloud Migration Poised to Unlock Data


Recent advances in tools for migrating legacy applications to the cloud have altered the mainframe market, but so far, few U.S. enterprises have adopted them, according to a new research report

DGAP-Adhoc: alstria office REIT-AG intends to take up debts in the amount of presumably up to EUR 850 million, the expected proceeds shall be used to return approx. EUR 1 billion of capital to the shareholders
DGAP-Adhoc: alstria office REIT-AG intends to take up debts in the amount of presumably up to EUR 850 million, the expected proceeds shall be used to return approx. EUR 1 billion of capital to the shareholders
DGAP-Adhoc: alstria office REIT-AG intends to take up debts in the amount of presumably up to EUR 850 million, the expected proceeds shall be used to return approx. EUR 1 billion of capital to the shareholders
LivaNova Initiates Targeted Commercial Launch of the Essenz Patient Monitor for Cardiopulmonary Bypass Procedures
LivaNova Initiates Targeted Commercial Launch of the Essenz Patient Monitor for Cardiopulmonary Bypass Procedures


LivaNova PLC (NASDAQ: LIVN), a market-leading medical technology and innovation company, today announced receipt of regulatory approvals and the start of a targeted commercial launch for the

Guess?, Inc. Files Definitive Proxy Materials and Investor Presentation
Guess?, Inc. Files Definitive Proxy Materials and Investor Presentation


Guess?, Inc. (NYSE: GES) (“Guess” or the “Company”) today announced that it has filed definitive proxy materials with the U.S. Securities and Exchange Commission (“SEC”) as well as an investor

FSD Pharma Announces Cancellation of Certain Shares Issued to Former Chief Executive Officer Dr. Raza Bokhari
FSD Pharma Announces Cancellation of Certain Shares Issued to Former Chief Executive Officer Dr. Raza Bokhari


FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“FSD Pharma” or the “Company”), a life sciences holding company dedicated to building a portfolio of assets and biotech solutions, announced

Agilent Highlights Genomics and Cell Analysis Solutions for Cancer Research at AACR 2022:
Agilent Highlights Genomics and Cell Analysis Solutions for Cancer Research at AACR 2022


Agilent Technologies Inc. (NYSE: A) today announced cancer research innovations in cell analysis and genomics that will be on show at the American Association for Cancer Research Annual Meeting

Clovis Oncology Highlights Presentations on FAP-2286 and Rubraca® (Rucaparib) at the AACR Annual Meeting 2022
Clovis Oncology Highlights Presentations on FAP-2286 and Rubraca® (Rucaparib) at the AACR Annual Meeting 2022


Clovis Oncology, Inc. (NASDAQ: CLVS), announced today that two abstracts featuring non-clinical data from studies evaluating FAP-2286 and Rubraca and a Trial-in-Progress poster detailing the Phase

Neustar, a TransUnion Company, Brings Unified Identity To Google Cloud Analytics Hub
Neustar, a TransUnion Company, Brings Unified Identity To Google Cloud Analytics Hub


Neustar, Inc., a TransUnion company, today announced that its Neustar Unified Identity™ data and identity resolution capabilities are now available in the Google Cloud Analytics Hub.



Marketers

Molson Coors Beverage Company to Webcast 2022 First Quarter Earnings Conference Call
Molson Coors Beverage Company to Webcast 2022 First Quarter Earnings Conference Call


Molson Coors Beverage Company (NYSE: TAP, TAP.A; TSX: TPX.B, TPX.A) will host a webcast of the company’s 2022 First Quarter Earnings Conference Call with investors and financial analysts at 11:00

DGAP-AGM: HUGO BOSS AG: Announcement  of the Convening of the General Meeting in Bahnhofstrasse 86, 70794 Filderstadt on 24.05.2022 according to article 121 AktG (German Stock Companies Act) with the objective of Europe-wide distribution
DGAP-AGM: HUGO BOSS AG: Announcement of the Convening of the General Meeting in Bahnhofstrasse 86, 70794 Filderstadt on 24.05.2022 according to article 121 AktG (German Stock Companies Act) with the objective of Europe-wide distribution
DGAP-AGM: HUGO BOSS AG: Announcement of the Convening of the General Meeting in Bahnhofstrasse 86, 70794 Filderstadt on 24.05.2022 according to article 121 AktG (German Stock Companies Act) with the objective of Europe-wide distribution
Form 8.3 - The Vanguard Group, Inc.: NortonLifeLock Inc.
Form 8.3 - The Vanguard Group, Inc.: NortonLifeLock Inc.
Form 8.3 - The Vanguard Group, Inc.: NortonLifeLock Inc.
Novocure Announces 19 Presentations at American Association for Cancer Research (AACR) Annual Meeting 2022 Suggesting Broad Applicability of Tumor Treating Fields
Novocure Announces 19 Presentations at American Association for Cancer Research (AACR) Annual Meeting 2022 Suggesting Broad Applicability of Tumor Treating Fields


Novocure (NASDAQ: NVCR) today announced 19 presentations on Tumor Treating Fields (TTFields) will be delivered at the American Association for Cancer Research (AACR) Annual Meeting 2022, to be held

DGAP-News: Deutsche Telekom AG: dividend announcement
DGAP-News: Deutsche Telekom AG: dividend announcement
DGAP-News: Deutsche Telekom AG: dividend announcement
TUI AG: Directorate change: https://upload.wikimedia.org/wikipedia/commons/1/1c/TUI_Logo_neu.png
TUI AG: Directorate change
TUI AG: Directorate change
Howmet Aerospace Releases 2021 Environmental, Social and Governance Report
Howmet Aerospace Releases 2021 Environmental, Social and Governance Report


Howmet Aerospace (NYSE:HWM) has released its 2021 Environmental, Social and Governance (ESG) Report. The report highlights the Company’s commitment and approach to sustainability, as well as

Technip Energies Announces Publication Date for First Quarter 2022 Financial Results and Conference Call
Technip Energies Announces Publication Date for First Quarter 2022 Financial Results and Conference Call


Technip Energies (PARIS:TE) will issue its first quarter 2022 financial results on Monday April 25, 2022, at 07:30 CET. The Company will host a results conference call on the same day at 13:00 CET

DGAP-Adhoc: Beiersdorf Aktiengesellschaft: Sales growth in the first quarter of 2022 above capital markets expectations
DGAP-Adhoc: Beiersdorf Aktiengesellschaft: Sales growth in the first quarter of 2022 above capital markets expectations
DGAP-Adhoc: Beiersdorf Aktiengesellschaft: Sales growth in the first quarter of 2022 above capital markets expectations
SES Shareholders Approve All Resolutions at Annual General Meeting and Extraordinary General Meeting
SES Shareholders Approve All Resolutions at Annual General Meeting and Extraordinary General Meeting


SES held its Annual General Meeting (AGM) and an Extraordinary General Meeting (EGM) yesterday in Betzdorf, Luxembourg.



The shareholders approved all proposed resolutions, notably the company's

Nordea Bank Abp: Transaction in Own Shares
Nordea Bank Abp: Transaction in Own Shares
Nordea Bank Abp: Transaction in Own Shares
DGAP-News: Evotec achieves programme designation in neuroscience collaboration with Bristol Myers Squibb
DGAP-News: Evotec achieves programme designation in neuroscience collaboration with Bristol Myers Squibb
DGAP-News: Evotec achieves programme designation in neuroscience collaboration with Bristol Myers Squibb
Holcim publishes agenda for 2022 Annual General Meeting
Holcim publishes agenda for 2022 Annual General Meeting
Holcim publishes agenda for 2022 Annual General Meeting